RAPP RAPPORT THERAPEUTICS INC
FollowStock (common), issuer CIK 2012593
Filings received so far for Q3 2026: 4 13F filers report a position in RAPP shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
| Owner | Date | Shares | Price | Filing |
|---|---|---|---|---|
| Ceesay Abrahamdirector, officer (Chief Executive Officer) | 2026-10-07 | -1,147 S | $30.66 | Form 4 |
| Ceesay Abrahamdirector, officer (Chief Executive Officer) | 2026-10-06 | -3,375 S | $32.0314 | Form 4 |
13F holders, Q3 2026
Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| GAMMA Investing LLC | 539 | $18.1K | <0.01% | +131 | 13F-HRTimeline |
| MassMutual Private Wealth & Trust, FSB | 163 | $5.48K | <0.01% | 0 | 13F-HRTimeline |
| Versant Capital Management, Inc | 27 | $907 | <0.01% | 0 | 13F-HRTimeline |
| Farther Finance Advisors, LLC | 1 | $34 | <0.01% | new | 13F-HRTimeline |
Events
Ceesay Abraham sold 4,522 RAPP shares between 2026-10-06 and 2026-10-07, Form 4 filed 2026-10-08. 0001193125-26-417919
Accepted , ingested